Medicare's $50 obesity drug program is proving popular, pharmacy chains say
Demand for GLP-1 obesity drugs has been strong in the month and a half since the Medicare Bridge program launched, according to two of the biggest pharmacy chains.
Eligible beneficiaries can get the medicines for $50 a month.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.npr.org — the content belongs to NPR Health.
